Abstract
A hallmark of human cancer is global DNA hypomethylation (GDHO), but the mechanisms accounting for this defect and its pathological consequences have not been defined in human epithelial ovarian cancer (EOC). In EOC, GDHO was associated with advanced disease and reduced overall and disease-free survival. GDHO(+) EOC was enriched for a proliferative gene expression signature, including CCNE1 and FOXM1 overexpression. DNA hypomethylation preferentially occurred within genomic blocks (hypomethylated blocks) overlapping late-replicating, lamina-associated domains, PRC2 binding, and H3K27me3. Increased proliferation coupled with hypomethylated block formation at late replicating regions suggested passive hypomethylation, which was further supported by the observation that cytosine DNA methyltransferases (DNMTs) and UHRF1 showed significantly reduced expression in GDHO(+) EOC, after normalization to proliferation markers. Importantly, GDHO(+) EOC showed elevated chromosomal instability (CIN), and copy number alterations (CNA) were enriched at hypomethylated blocks. Together, these findings implicate a passive demethylation mechanism for GDHO that promotes genomic instability and poor prognosis in EOC.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
All funding is reported in the contents of the manuscript.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Non-standard abbreviations
- CG gene
- cancer germline or cancer testis gene
- CIN
- chromosomal instability
- CNA
- copy number alteration
- DAC
- decitabine, 5-aza-2’-deoxycytidine
- DEG
- differentially expressed gene
- DE-CG gene
- differentially expressed CG gene
- DMC
- differentially methylated CpG site
- DMR
- differentially methylated region
- DNMT
- cytosine DNA methyltransferase
- EOC
- epithelial ovarian cancer
- FDR
- false discovery rate
- FTE
- fallopian tube epithelia
- GDHO
- global DNA hypomethylation
- GSEA
- gene set enrichment analysis
- HGSOC
- high grade serous ovarian cancer
- IPA
- Ingenuity Pathway Analysis
- LAD
- lamina-associated domain
- NE
- normal epithelia (OSE + FTE)
- NO
- bulk normal ovary
- OSE
- ovarian surface epithelia
- PCA
- principal component analysis
- RE
- repetitive DNA elements
- RMA
- robust multichip average
- TET
- Ten-eleven translocation methylcytosine dioxygenase
- TF
- transcription factor
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
2
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos